Talzenna is an oral inhibitor of PARP enzymes, which play a critical role in the repair of single DNA damage. The active substance is approved for the treatment of HER2 negative, locally advanced or metastatic breast cancer with BRCA mutations…
Active ingredient: Talazoparib
Prescription medicine
Дозировка | 0.25 Mg, 1 Mg |
---|